Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold
Status:
Terminated
Trial end date:
2018-04-16
Target enrollment:
Participant gender:
Summary
This will be a randomized, double-blind, placebo controlled, parallel-group Phase 2 study to
evaluate the efficacy of a new formulation of phenylephrine HCl and a currently marketed
phenylephrine HCl for relief of nasal congestion in subjects with naturally occurring cold
symptoms.